Covered recipient · General Payments record
MARIA D PARDI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$267.05
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.36 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $27.49 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.05 | 1 |
| DEXCOM, INC. | $22.63 | 1 |
| GlaxoSmithKline, LLC. | $22.34 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.33 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.51 | 1 |
| Astellas Pharma US Inc | $18.24 | 1 |
| Medtronic, Inc. | $16.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.24 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374709 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.33 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086120604 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.05 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118131553 | CMS |
| Dexcom, Inc. | $22.63 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153319158 | CMS |
| Exact Sciences Corporation | $27.49 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114796112 | CMS |
| GlaxoSmithKline, LLC. | $22.34 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116301080 | CMS |
| Medtronic, Inc. | $16.77 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119457769 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.51 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153555103 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.